24.85
+0.05
+(0.20%)
At close: 1:33:00 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-276,952.00
-204,133.00
-190,389.00
-200,606.00
-167,378.00
Investing Cash Flow
-72,880.00
-235,978.00
-203,976.00
-35,518.00
-42,205.00
Financing Cash Flow
347,792.00
453,020.00
238,707.00
251,923.00
242,136.00
End Cash Position
78,903.00
77,729.00
64,819.00
220,481.00
204,685.00
Capital Expenditure
-44,221.00
-30,207.00
-11,000.00
-21,306.00
-48,159.00
Issuance of Capital Stock
--
460,000.00
5,062.00
300,000.00
--
Issuance of Debt
-77,994.00
27,000.00
270,000.00
--
280,000.00
Repayment of Debt
-2,000.00
-2,000.00
-15,099.00
-30,000.00
-21,269.00
Free Cash Flow
-321,173.00
-234,340.00
-201,389.00
-221,912.00
-215,537.00
12/31/2020 - 7/15/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4168.TWO GlycoNex Incorporation
24.00
0.00%
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%
4728.TWO Sunmax Biotechnology Co., Ltd.
275.00
+0.18%
4130.TWO Genovate Biotechnology Co., Ltd.
25.30
+1.81%
4726.TWO Mycenax Biotech Inc.
40.25
0.00%
6662.TWO BioLASCO Taiwan Co., Ltd.
33.00
-0.30%
4192.TWO SynCore Biotechnology Co.,Ltd
33.40
-0.15%
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%